3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
208
Leukemia, Lymphocytic, Chronic, B-Cell
136
Precursor Cell Lymphoblastic Leukemia-Lymphoma
132
Hematologic Neoplasms
113
Myelodysplastic Syndromes
96
Leukemia
82
Lymphoma
65
Lymphoma, Non-Hodgkin
57
Multiple Myeloma
43
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
37
Leukemia, Myelomonocytic, Chronic
35
Neoplasms
31
Recurrence
27
Myeloproliferative Disorders
27
Burkitt Lymphoma
25
Lymphoma, Mantle-Cell
23
Leukemia, Biphenotypic, Acute
23
Lymphoma, Large B-Cell, Diffuse
22
Lymphoma, Follicular
20
Lymphoma, B-Cell, Marginal Zone
20
Lymphoma, B-Cell
20
Leukemia, Myeloid, Chronic-Phase
16
Leukemia, B-Cell
16
Hodgkin Disease
16
Primary Myelofibrosis
15
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
15
Waldenstrom Macroglobulinemia
14
Hematologic Diseases
14
Anemia, Refractory, with Excess of Blasts
11
Neoplasm, Residual
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Neoplasms, Experimental
×
Other hematologic neoplasm
×
Clear all
NCT03155191
2024-11-20
TBI-1501
Takara Bio Inc.
Phase 1/2
Active not recruiting
21 enrolled